These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3898672)

  • 21. [The relationship of the antigenic characteristics of the tick-borne encephalitis virus to the level of the protective activity of inactivated cultured vaccines].
    Vorob'eva MS; Rasshchepkina MN
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):35-7. PubMed ID: 1301660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Assessment of the immunologic effectiveness of a concentrated purified vaccine against tick-borne encephalitis in experiments on animals].
    Korovina GI; Titova TS; Churnosov EV
    Tr Inst Im Pastera; 1989; 65():150-5. PubMed ID: 2629183
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens.
    Harabacz I; Bock H; Jüngst C; Klockmann U; Praus M; Weber R
    Vaccine; 1992; 10(3):145-50. PubMed ID: 1557929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new vaccine against tick-borne encephalitis: initial trial in man including a dose-response study.
    Bock HL; Klockmann U; Jüngst C; Schindel-Künzel F; Theobald K; Zerban R
    Vaccine; 1990 Feb; 8(1):22-4. PubMed ID: 2316281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Possible use of a concentrated vaccine against tick-borne encephalitis for immunizing donors to obtain specific immunoglobulin].
    Subbotina LS; Beliavskaia NA; Matiukhina LV; Kopylova LM; Kul'chitskaia TI
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Sep; (9):71-4. PubMed ID: 6506942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Live vaccine against tick-borne encephalitis. Antigenic activity].
    Dubov AV; Kozlov LB; Molotilov BA; Feneva NA
    Vopr Virusol; 1972; 17(6):703-5. PubMed ID: 4677049
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the immunizing potency of tick-borne encephalitis vaccines.
    Gall W
    Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562
    [No Abstract]   [Full Text] [Related]  

  • 31. [Study of the reactivity and immunogenicity of FSME-IMMUN vaccine against tick-borne meningoencephalitis].
    Borcić B; Majerus-Misić L; Raos B; Punda V; Bujić N; Toth D
    Lijec Vjesn; 1984 Oct; 106(10):425-8. PubMed ID: 6503595
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vaccination against tick-borne encephalitis using an inactivated vaccine].
    Duniewicz M; Markvart K; Vlasimská H; Heinz F; Kulková H
    Cas Lek Cesk; 1983 Aug; 122(32-33):1000-2. PubMed ID: 6627307
    [No Abstract]   [Full Text] [Related]  

  • 33. Different immune responses after intradermal and intramuscular administration of vaccine against tick-borne encephalitis virus.
    Zoulek G; Roggendorf M; Deinhardt F; Kunz C
    J Med Virol; 1986 May; 19(1):55-61. PubMed ID: 3701303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to different tick-borne encephalitis vaccines as revealed by lymphocyte blast transformation and virus neutralization tests.
    Dzagurov SG; Vorobieva MS; Shalamberidze TD; Karpovich LG; Blokha VV; Bukovskaya NS
    Acta Virol; 1984 Sep; 28(5):388-94. PubMed ID: 6151352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Concentrated purified vaccine against tick-borne encephalitis. An immunological evaluation in experiments on mice].
    Khotlubeĭ LI; Pervikov IuV; Krutianskaia GL; Vil'ner LM; Semenov BF
    Vopr Virusol; 1982; 27(3):316-20. PubMed ID: 7123913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children.
    Eder G; Kollaritsch H
    Vaccine; 2003 Sep; 21(25-26):3575-83. PubMed ID: 12922085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
    Wright PF; Ankrah S; Henderson SE; Durbin AP; Speicher J; Whitehead SS; Murphy BR; Pletnev AG
    Vaccine; 2008 Feb; 26(7):882-90. PubMed ID: 18207289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the reactogenicity and immunogenicity of new Soviet and commercial vaccines for preventing Japanese encephalitis].
    Sumarovkov AA; Grachev VP; Kharazian EG; Shkol'nik RIa; Vorob'eva MS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Sep; (9):74-9. PubMed ID: 6314716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the serological response after vaccination against tick-borne encephalitis in Sweden.
    Vene S; Haglund M; Lundkvist A; Lindquist L; Forsgren M
    Vaccine; 2007 Jan; 25(2):366-72. PubMed ID: 16959384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.